AKOS 94123
- $110 - $500.42
- Product name: AKOS 94123
- CAS: 40106-36-3
- MF: C13H14N2O3S
- MW: 278.33
- EINECS:
- MDL Number:MFCD00089147
- Synonyms:AURORA 20518;AKOS 94123;2-ETHOXYCARBONYL-3,4,5,6,7,8-HEXAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4-ONE;4-oxo-3,4,5,6,7,8-hexahydro-benzo[4,5]thieno[2,3-d]pyrimidine-2-carboxylic acid ethyl ester;ethyl 4-hydroxy-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-2-carboxylate;[1]Benzothieno[2,3-d]pyrimidine-2-carboxylic acid, 1,4,5,6,7,8-hexahydro-4-oxo-, ethyl ester
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 250mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0309516
- Product description2-ETHOXYCARBONYL-3,4,5,6,7,8-HEXAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4-ONE 95.00%
- Packaging5MG
- Price$500.42
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS647535
- Product description2-ETHOXYCARBONYL-3,4,5,6,7,8-HEXAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4-ONE AldrichCPR
- Packaging250mg
- Price$110
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0309516 | 2-ETHOXYCARBONYL-3,4,5,6,7,8-HEXAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4-ONE 95.00% | 5MG | $500.42 | 2021-12-16 | Buy |
Sigma-Aldrich | S647535 | 2-ETHOXYCARBONYL-3,4,5,6,7,8-HEXAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4-ONE AldrichCPR | 250mg | $110 | 2024-03-01 | Buy |
Properties
Melting point :207-209 °C
Boiling point :480.3±55.0 °C(Predicted)
Density :1.54±0.1 g/cm3(Predicted)
pka :-3.28±0.20(Predicted)
Boiling point :480.3±55.0 °C(Predicted)
Density :1.54±0.1 g/cm3(Predicted)
pka :-3.28±0.20(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|